Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

EVLO Stock Annual Income Statement. Download in Excel

Evelo Biosciences Inc. logo

Evelo Biosciences Inc.

Sector: Healthcare   

Industry: Biotechnology

0.00
 
USD
  
0.00
  
(0.00%)
Previous close: 0.0005  Open: 0.0005  Bid:   Ask:
52 week range    
0.00   
   0.08
Mkt Cap: 0 M  Avg Vol (90 Days): 1,064
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

15
Technical
21
Quality
How are these ranks calculated?
Search for a stock

Financials

EVLO Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends4 M
Basic EPS from continuing operations-47.4-46.2-1.31
Basic EPS total-47.4-46.2-1.31
Basic weighted shares outstanding1 M2 M2 M3 M87 M
Depreciation-2 M-2 M2 M2 M2 M
DepreciationAndAmortization-2 M-2 M2 M2 M2 M
Diluted EPS total-55.6-53.4-47.4-46.2-1.31
Diluted normalized net income/share-46.2-1.31
Diluted weighted shares outstanding1 M2 M2 M3 M87 M
GainOnSaleOfSecurity-2 M-4 M-5 M
GeneralAndAdministrativeExpense18 M23 M22 M32 M30 M
Gross operating profit200000.0500000.0
Income before tax-57 M-85 M-93 M-122 M-114 M
Income taxes200000.0409000.0428000.0930000.0
Interest income1 M1 M
InterestExpenseNonOperating2 M4 M5 M
MiscOtherSpecialCharges-406000.026000.0738000.0-3 M-459000.0
Net income from total operations-57 M-85 M-94 M-122 M-115 M
NetIncomeCommonStockholders-61 M-85 M-94 M-122 M-115 M
NetIncomeContinuousOperations-57 M-85 M-94 M-122 M-115 M
NetNonOperatingInterestIncomeExpense2 M1 M5 M
Normalized income-96 M-90 M
Operating income-58 M-86 M-92 M-115 M-108 M
Operating income before depreciation (EBITDA)-55 M-84 M-89 M-116 M-107 M
OperatingExpense-58 M-86 M92 M115 M108 M
Other income net406000.0-26000.01 M6 M-459000.0
Other special charges-300000.0
OtherGandA18 M23 M22 M32 M30 M
OtherOperatingExpenses-58 M-86 M3 M3 M3 M
OtherunderPreferredStockDividend4 M
PreferredStockDividends4 M
RentAndLandingFees18 M23 M
Research & development expense40 M63 M70 M84 M79 M
ResearchExpense40 M63 M70 M84 M79 M
SalariesAndWages-6 M-8 M
Selling Gen & administrative expense18 M23 M22 M32 M30 M
Special income/charges300000.0
Total Income available for interest expense (EBIT)-57 M-85 M-91 M-118 M-109 M
Total common shares outstanding2 M3 M3 M111 M
Total net income-57 M-85 M-94 M-122 M-115 M
Total ordinary shares19 M19 M19 M19 M19 M
Total revenues200000.0500000.0
TotalExpenses-58 M-86 M92 M115 M108 M
TotalRevenue200000.0500000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University